100 related articles for article (PubMed ID: 2112606)
21. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
22. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Fowler SE; Stillman RJ
Obstet Gynecol; 1994 Feb; 83(2):173-9. PubMed ID: 8290177
[TBL] [Abstract][Full Text] [Related]
23. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial.
Meschia M; Bruschi F; Soma M; Amicarelli F; Paoletti R; Crosignani P
Menopause; 1998; 5(3):157-62. PubMed ID: 9774761
[TBL] [Abstract][Full Text] [Related]
24. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
25. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
26. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
27. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
[TBL] [Abstract][Full Text] [Related]
29. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
Milner MH; Sinnott MM; Cooke TM; Kelly A; McGill T; Harrison RF
Obstet Gynecol; 1996 Apr; 87(4):593-9. PubMed ID: 8602314
[TBL] [Abstract][Full Text] [Related]
30. Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Lehtonen A; Grönroos M; Marniemi J; Peltonen P; Mäntylä M; Niskanen J; Rautio A; Hietanen E
Horm Metab Res; 1985 Jan; 17(1):32-4. PubMed ID: 3155702
[TBL] [Abstract][Full Text] [Related]
31. Postmenopausal hormone replacement with a combination estrogen-progestin regimen for five days per week.
Mishell DR; Shoupe D; Moyer DL; Roy S; Page MA
J Reprod Med; 1991 May; 36(5):351-5. PubMed ID: 2061882
[TBL] [Abstract][Full Text] [Related]
32. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
[TBL] [Abstract][Full Text] [Related]
33. The effects of different doses of medroxyprogesterone acetate on serum lipids, lipoprotein levels and atherogenic index in the menopausal period.
Aygen EM; Başbuğ M; Tayyar M; Kaya E
Gynecol Endocrinol; 1998 Aug; 12(4):267-72. PubMed ID: 9798136
[TBL] [Abstract][Full Text] [Related]
34. Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens.
Yancey MK; Hannan CJ; Plymate SR; Stone IK; Friedl KE; Wright JR
Fertil Steril; 1990 Nov; 54(5):778-82. PubMed ID: 2226911
[TBL] [Abstract][Full Text] [Related]
35. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
Denke MA
Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
[TBL] [Abstract][Full Text] [Related]
36. Continuous estrogen/progestin therapy in menopause.
Prough SG; Aksel S; Wiebe RH; Shepherd J
Am J Obstet Gynecol; 1987 Dec; 157(6):1449-53. PubMed ID: 2827483
[TBL] [Abstract][Full Text] [Related]
37. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
Taechakraichana N; Holinka CF; Haines CJ; Subramaniam R; Tian XW; Ausmanas MK
Climacteric; 2007 Jun; 10(3):225-37. PubMed ID: 17487649
[TBL] [Abstract][Full Text] [Related]
38. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy and lipoprotein changes during early menopause.
Egeland GM; Kuller LH; Matthews KA; Kelsey SF; Cauley J; Guzick D
Obstet Gynecol; 1990 Nov; 76(5 Pt 1):776-82. PubMed ID: 2170887
[TBL] [Abstract][Full Text] [Related]
40. Effects of 2 years of hormone replacement upon bone mass, serum lipids and lipoproteins.
Webber CE; Blake JM; Chambers LF; Roberts JG
Maturitas; 1994 May; 19(1):13-23. PubMed ID: 7935028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
